Sutinib 50mg 7 Capsules

✔️ Key Uses of Sutinib 50

• Kidney Cancer (Renal Cell Carcinoma)
• Gastrointestinal Stromal Tumor (GIST)

✔️ Key Side Effects

• Fatigue
• Skin or hair discoloration
• Digestive issues (nausea, vomiting, diarrhea, or constipation)
• High blood pressure and joint pain

✔️ Sunitinib can cause a range of side effects, including:

• Nausea and vomiting
• Weakness or fatigue
• Skin rashes or discoloration
• Abdominal pain, indigestion, and diarrhea
• Constipation and dry skin
• High blood pressure
• Blisters on hands and feet
• Mouth inflammation (stomatitis)
• Hair discoloration
• Back or joint pain
• Taste changes or loss of appetite

More severe symptoms may include significant bleeding, difficulty healing wounds, and dangerously low blood sugar levels, especially in diabetic patients. Blood pressure

✔️ Missed Doses 0f Sutinib 50

If you forget to take a dose, skip it and continue with your regular dosing schedule. Do not double the dose to make up for the missed one.

✔️ How Sunitinib Works

Sunitinib belongs to a class of medications called multikinase inhibitors. It blocks the activity of specific proteins (tyrosine kinases) that promote the growth of cancer cells and the formation of blood vessels that supply tumors. By targeting these mechanisms, Sunitinib prevents the spread of cancer cells and tumor progression.

✔️ Quick Tips for Patients

• Sunitinib is commonly used to treat conditions such as kidney cancer, gastrointestinal stromal tumors (GIST), and, in some cases, thyroid cancer.
• Take this medication at the same time daily to ensure steady levels in your bloodstream.
• Stay hydrated and inform your doctor if diarrhea persists or if you notice blood in your stool.
• Monitor your blood pressure regularly and report any symptoms of extremely high blood pressure, such as headaches, visual changes, or nausea, to your doctor.
• If you are undergoing surgery or dental procedures, inform your healthcare provider that you are taking Sunitinib, as it may affect healing.
• Avoid this medication if you are pregnant, breastfeeding, or planning to conceive, and use reliable contraception during treatment.

✔️ Interaction

Strong CYP3A4 Inhibitors

Sunitinib's plasma concentration can significantly increase when administered alongside strong CYP3A4 inhibitors, such as Ketoconazole. This interaction leads to elevated drug levels, which may enhance the risk of adverse effects.

• When combined with Ketoconazole, Sunitinib’s combined concentration (Sunitinib + its active metabolite) increases by 49% (Cmax) and 51% (AUC0-∞).
• Similar effects may occur with other strong CYP3A4 inhibitors, including:
  • Itraconazole
  • Clarithromycin
  • Atazanavir
  • Indinavir
  • Nefazodone
  • Nelfinavir
  • Ritonavir
  • Saquinavir
  • Telithromycin
  • Voriconazole
• Consumption of grapefruit or grapefruit juice may also raise Sunitinib plasma concentrations.
• Whenever possible, choose alternative medications with minimal or no CYP3A4 inhibition potential.
• If coadministration with a strong inhibitor is unavoidable, consider reducing the Sunitinib dosage to mitigate the risk of toxicity.

CYP3A4 Inducers

CYP3A4 inducers, such as Rifampin, can decrease the plasma concentration of Sunitinib, potentially reducing its therapeutic effectiveness.

• Clinical Data: When Sunitinib is coadministered with Rifampin, its combined concentration decreases by 23% (Cmax) and 46% (AUC0-∞).
• Other Inducers: Similar interactions can occur with:
  • Dexamethasone
  • Phenytoin
  • Carbamazepine
  • Rifabutin
  • Rifapentine
  • Phenobarbital
  • St. John’s Wort
• St. John’s Wort can unpredictably reduce Sunitinib levels and should be strictly avoided during treatment.
• Use alternative medications with no or minimal CYP3A4 induction potential.
• If coadministration with an inducer is necessary, consider increasing the Sunitinib dosage to maintain efficacy, under close medical supervision.

✔️ Contraindications

Sunitinib is contraindicated in individuals with a known hypersensitivity to the drug or any of its components.

✔️ Use During Pregnancy and Breastfeeding

Sunitinib is not recommended for use during pregnancy or while breastfeeding due to its potential risks to the baby. Both men and women undergoing treatment are advised to use effective contraception during and for at least one month after completing therapy to prevent pregnancy.

✔️ Precautions & Warnings

1. This medication may delay the body’s ability to heal wounds. Be cautious when shaving or using sharp tools to avoid injury.
2. Sunitinib may lower blood sugar levels to the point of fainting. If you have diabetes, regularly monitor your blood sugar and consult your doctor if adjustments to your diabetes medication are necessary.
3. Inform your doctor if you have pre-existing heart, liver, kidney, or bleeding disorders, as these may affect your treatment.
4. Certain medications, including blood thinners and supplements, may interact with Sunitinib. Always disclose all medications and supplements you are taking to your healthcare provider.

✔️ Storage:

Store at 25°C in a cool and dry place, away from light. Keep out of the reach of children.